4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-23-000851
CHIEF EXECUTIVE OFFICER acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2023-02-08 | Grant or award | +500,000 | 5,971,873 | D | ||
| Derivatives | |||||||
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2023-02-08 | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | D | ||
Loading xslF345X03/ownership.xml…